These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2048199)

  • 1. Acceptance of H-Y-disparate corneal grafts despite concomitant immunization of the recipient.
    He YG; Ross J; Callanan D; Niederkorn JY
    Transplantation; 1991 Jun; 51(6):1258-62. PubMed ID: 2048199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The differential effects of donor versus host Langerhans cells in the rejection of MHC-matched corneal allografts.
    Ross J; He YG; Pidherney M; Mellon J; Niederkorn JY
    Transplantation; 1991 Nov; 52(5):857-61. PubMed ID: 1949172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The significance of gender incompatibility in donors and recipients and the role of minor histocompatibility antigens in corneal transplantation].
    Hasková Z; Filipec M; Holán V
    Cesk Slov Oftalmol; 1997 May; 53(2):128-35. PubMed ID: 9296861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of tissue culture on corneal immunogenicity.
    Gabric N; Dekaris I; Suman L; Karaman Z; Mravicic I
    Exp Eye Res; 1999 Mar; 68(3):277-82. PubMed ID: 10079135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine orthotopic corneal transplantation in high-risk eyes. Rejection is dictated primarily by weak rather than strong alloantigens.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1130-8. PubMed ID: 9152232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minor H, rather than MHC, alloantigens offer the greater barrier to successful orthotopic corneal transplantation in mice.
    Sano Y; Ksander BR; Streilein JW
    Transpl Immunol; 1996 Mar; 4(1):53-6. PubMed ID: 8762011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of oral immunization on corneal allograft survival.
    He YG; Mellon J; Niederkorn JY
    Transplantation; 1996 Mar; 61(6):920-6. PubMed ID: 8623161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that the fate of class II-disparate corneal grafts is determined by the timing of class II expression.
    Ross J; Callanan D; Kunz H; Niederkorn J
    Transplantation; 1991 Feb; 51(2):532-6. PubMed ID: 1994550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orthotopic corneal transplantation in mice--evidence that the immunogenetic rules of rejection do not apply.
    Sonoda Y; Streilein JW
    Transplantation; 1992 Oct; 54(4):694-704. PubMed ID: 1412761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of mismatches for major histocompatibility complex and minor antigens on corneal graft rejection.
    Nicholls SM; Bradley BB; Easty DL
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2729-34. PubMed ID: 1894472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2176-85. PubMed ID: 7558710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of cell-mediated immune responses elicited by orthotopic corneal allografts in mice.
    Sonoda Y; Sano Y; Ksander B; Streilein JW
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):427-34. PubMed ID: 7843911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
    Yamada J; Kurimoto I; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavior of male-specific minor histocompatibility antigen in skin and limb transplantation.
    Muramatsu K; Kurokawa Y; Ihara K; Sakamoto S; You-Xin S; Kawai S
    J Surg Res; 2003 Nov; 115(1):106-12. PubMed ID: 14572780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class I disparate corneal grafts enjoy afferent but not efferent blockade of the immune response.
    Ross J; He YG; Niederkorn JY
    Curr Eye Res; 1991 Sep; 10(9):889-92. PubMed ID: 1790719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transplantation immunity and tolerance in the eye: rejection and acceptance of orthotopic corneal allografts in mice.
    Holán V; Hasková Z; Filipec M
    Transplantation; 1996 Oct; 62(8):1050-4. PubMed ID: 8900299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection.
    Haskova Z; Sproule TJ; Roopenian DC; Ksander AB
    Transplantation; 2003 Apr; 75(8):1368-74. PubMed ID: 12717232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The critical role of lymph nodes in corneal alloimmunization and graft rejection.
    Yamagami S; Dana MR
    Invest Ophthalmol Vis Sci; 2001 May; 42(6):1293-8. PubMed ID: 11328742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of topical interleukin-1 receptor antagonist (IL-1ra) on corneal allograft survival in presensitized hosts.
    Dekaris IJ; Yamada JJ; Streilein WJ; Dana RM
    Curr Eye Res; 1999 Nov; 19(5):456-9. PubMed ID: 10520223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The immunogenic privilege of corneal allografts.
    Niederkorn JY; Peeler JS; Ross J; Callanan D
    Reg Immunol; 1989; 2(2):117-24. PubMed ID: 2701814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.